Laboratorios RichmondC.I.F Balance Sheet Health
Financial Health criteria checks 2/6
Laboratorios RichmondC.I.F has a total shareholder equity of ARS61.0B and total debt of ARS136.4B, which brings its debt-to-equity ratio to 223.8%. Its total assets and total liabilities are ARS248.0B and ARS187.0B respectively. Laboratorios RichmondC.I.F's EBIT is ARS13.0B making its interest coverage ratio -27.6. It has cash and short-term investments of ARS9.3B.
Key information
223.8%
Debt to equity ratio
AR$136.44b
Debt
| Interest coverage ratio | -27.6x |
| Cash | AR$9.31b |
| Equity | AR$60.97b |
| Total liabilities | AR$187.00b |
| Total assets | AR$247.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RICH's short term assets (ARS57.7B) exceed its short term liabilities (ARS46.8B).
Long Term Liabilities: RICH's short term assets (ARS57.7B) do not cover its long term liabilities (ARS140.2B).
Debt to Equity History and Analysis
Debt Level: RICH's net debt to equity ratio (208.5%) is considered high.
Reducing Debt: RICH's debt to equity ratio has increased from 38.4% to 223.8% over the past 5 years.
Debt Coverage: RICH's debt is not well covered by operating cash flow (6%).
Interest Coverage: RICH earns more interest than it pays, so coverage of interest payments is not a concern.